Industry Solutions : Thermo Fisher Scientific

We can’t wait to see you in Montreal, Canada in 2026! In the meantime, please check out our key resources below.

Key Resources: We invite you to explore past content, including posters, testimonials, workshop recordings, and more.

FEATURED WEBPAGES >>

• NEW TSQ Certis Mass Spectrometer | Thermo Fisher Scientific - US
• Mass Spectrometer Affordability Programs | Thermo Fisher Scientific - US (Trade-in, Refurb, and Financing Solutions)
• Explore more Mass Spectrometry Solutions for Clinical Research | Thermo Fisher Scientific - US

2025 POSTERS >>

• Sensitive and selective quantitation of bile acids using targeted MS2/MS3 on the Thermo Scientific Stellar mass spectrometer
• Selective and sensitive quantitation of 18 steroids in human serum using the Thermo Scientific Stellar mass spectrometer
• Simultaneous quantitation and discovery (SQUAD) of fecal bile acids and conjugates in adults with autism spectrum disorder
• Detection and quantification of GLP-1 analogs in human plasma: A comprehensive analytical approach
• Smart solutions for high analyte concentrations and carryover in LC-MS monitoring
• Deciphering Spatial Variation in Lipid Profiles of X-Ray Irradiated Cells Using nLC and Orbitrap 240 MS
• Enhanced Sensitivity of a Modified Orbitrap Astral Mass Spectrometer for Deeper Proteome Coverage in Single-cell Proteomics Applications
• Highly Multiplex Targeted Proteomics Assays in Plasma using Stellar Mass Spectrometer with Adaptive RT
• Evaluation of prioritized peptide acquisition for multiplexed single-cell proteomics on a Thermo Scientific Orbitrap Astral Zoom mass spectrometer
• Using the New Thermo Scientific Stellar mass spectrometer to confirm and quantify 31 drugs of abuse, including THC, in oral fluid
• A novel ion source with integrated separation column and replaceable emitters facilitates ultra high-throughput multiplex PRM-MS

2025 WORKSHOPS >>

• Clinical LC-MS: Advancing Free Testosterone Measurement with QQQ Technologies" with Cleveland Clinic
• Extracellular Vesicle Biomarkers for Neurodegenerative Disease
• New frontiers in LC-MS - developing an efficient discovery to validation pipeline

2024 POSTERS >>

• Enhanced Detection of Hemoglobin Variants in Clinical Research by DBS and High- Resolution Accurate Mass (HRAM) MS
• Quantitation of a Panel of Per- and Polyfluoroalkyl Substances (PFAS) in Human Serum
• Empower the Confidence for Inborn Error of Metabolism Screening: Quantitation of Amino Acids and Acylcarnitines in Dried Blood Spots by Flow Injection – Orbitrap Mass Spectrometer
• Quantitation of an Oral Fluid Drug Panel Including THC Using High Resolution Accurate-Mass (HRAM) Orbitrap Mass Spectrometry

2024 WORKSHOPS >>

• Tony Maus, Ph.D., Assistant Professor, Department of Laboratory Medicine & Pathology, Mayo Clinic >>
  FAIMS: The perfect complement to established LC-MS/MS techniques
• Stefani Thomas, Ph.D., Assistant Professor, Department of Laboratory Medicine & Pathology, University of Minnesota Medical School >>
  An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples
• Jennifer Van Eyk, Ph.D., Director, Advanced Clinical Biosystems Institute, Cedars-Sinai Heart Institute >>
  Paradigm shift in biomarker translation: A pipeline to generate clinical grade biomarker candidates from DIA-MS discovery
• Yue Xuan, Ph.D., Senior Manager, Precision Medicine, Thermo Fisher Scientific >>
  Unlocking the potential of large-cohort proteomics studies with the Orbitrap Astral MS platform

2023 POSTERS >>

• High flow LC-MS analysis of plasma digest for protein identification
• Simultaneous Detection of Respiratory Infectious Diseases using Immunoprecipitation and Liquid Chromatography-Tandem Mass Spectrometry

2023 WORKSHOPS >>

• Jessica Colón-Franco, Ph.D., Cleveland Clinic Foundation >>
  No child lead behind: Development of a method for lead screening using dried blood spots
• Dr. Michael Lutz, Ph.D., Head of Global Business Development, Osteolabs GmbH Germany >>
  Advancing ICP-MS to clinical testing: A novel highly sensitive diagnostic platform for early detection and therapeutic monitoring of bone metabolic disorders
• Tony Hu, Ph.D., Professor Tulane University >>
  Peptidomic classification of mycobacterial proteins at sub-species resolution
• Ian Lewis, Ph.D., University of Calgary, Alberta >>
  LC-MS metabolomics: A new frontier in microbiology diagnostic testing

TESTIMONIALS >>

• Chris Gill, Ph.D., Professor Vancouver Island University >>
  Rapid MS tools to help researchers tackle opioid crisis
• Ian Lewis, Ph.D., University of Calgary >>
  New frontiers for pathogen detection
• Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota >>
  "Biomarker discovery/ biomarker translation is a team sport"
• Erin H. Seeley, Ph.D., University of Texas at Austin >>
  "We can do things other labs are not able to do"
• Timothy J. Garrett, Ph.D., Southest Center for Integrated Metabolomics >>
  Discover the technology delivering confident results for health and disease diagnostics